Michael Huber

Head Diagnostics and Development

University of Zurich

Switzerland

Research Interests

Explore related searches

Professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Michael Huber is the Head of Diagnostics and Development at the University of Zurich, Switzerland. His research focuses on viral transmission dynamics, particularly involving Norovirus, Enterovirus, and SARS-CoV-2, as well as the emergence of antiviral resistance and immune responses to viral infections. His recent publications reflect his expertise in virology and epidemiology, contributing valuable insights into infection control and public health during the COVID-19 pandemic.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (30)

Meta Roestenberg

Helmholtz Centre for Infection Research

NETHERLANDS

Michael Huber

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

Transmission dynamics of Norovirus GII and Enterovirus in Switzerland during the COVID-19 pandemic (2021–2022) as evidenced in wastewater

Inactivation of SARS-CoV-2 at acidic pH is driven by partial unfolding of spike.

Emergence of Bictegravir Resistance in a Treatment-Experienced PWH on Functional Monotherapy and Rapid Replacement by an Ancient Wild-Type Strain Following Transient Treatment Interruption

Retrospective Genotyping of Enteroviruses Using a Diagnostic Nanopore Sequencing Workflow

Genetic Diversity From Proviral DNA as a Proxy for Time Since HIV-1 Infection

No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials

Highly sensitive reporter cell line for detection of interferon types I–III and their neutralization by antibodies

Prevalence of HIV-1 drug resistance mutations in proviral DNA in the Swiss HIV Cohort Study, a retrospective study from 1995 to 2018

Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1

Swiss public health measures associated with reduced SARS-CoV-2 transmission using genome data

Rapid and sensitive single-sample viral metagenomics using Nanopore Flongle sequencing

Cohort Profile Update: The Swiss HIV Cohort Study (SHCS).

Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group

A Systematic Molecular Epidemiology Screen Reveals Numerous Human Immunodeficiency Virus (HIV) Type 1 Superinfections in the Swiss HIV Cohort Study

Similar But Different: Integrated Phylogenetic Analysis of Austrian and Swiss HIV-1 Sequences Reveal Differences in Transmission Patterns of the Local HIV-1 Epidemics

Multisystem Inflammation and Susceptibility to Viral infections in Human ZNFX1 Deficiency

External Quality Assessment of SARS-CoV-2 Sequencing: an ESGMD-SSM Pilot Trial across 15 European Laboratories.

Secondary attack rates from asymptomatic and symptomatic influenza virus shedders in hospitals: Results from the TransFLUas influenza transmission study.

Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity

Collaborators (30)

Meta Roestenberg

Benjamin Hale

Sebastian Hiller

Navid Sadri

Shotaro Torii

sabine yerly

Timothy Julian

Roger D Kouyos

Stefano Vavassori

Katharina Kusejko

P.P. Bosshard

Chaoran Chen

David Hughes

Teemu Kallonen

Ian Pichler

Matthias Cavassini

Jutte J.C. de Vries

Barbara Brotschi

Dominic Lenz

Tayfun Güngör

Alexandra Trkola

Liv Zimmermann

Heidi Petry

A. Ramette

Karin J. Metzner

Michael Gabbett

Andrés Antón Pagarolas

Huldrych Günthard

Philip TARR

Emma Hodcroft

Make your next move.